Company Profiles

driven by the PitchBook Platform

Seldar Pharma

Description

Developer of a drug for the treatment of irritable bowel syndrome with diarrhea. The company is developing ASP7147 which is in phase I Multiple Ascending Dose study.

2012

Founded

PRIVATE

Status

Series A

Latest Deal Type

$13M

Latest Deal Amount

$13M

Total Amount Raised

3

Investors

Description

Developer of a drug for the treatment of irritable bowel syndrome with diarrhea. The company is developing ASP7147 which is in phase I Multiple Ascending Dose study.

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Primary Office

520 US Highway 22 Suite 201 Bridgewater, NJ 08807United States +1 (908) 895-1200
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Seldar Pharma's full profile, request a free trial.

    Seldar Pharma Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Seldar Pharma Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Seldar Pharma Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Astellas Venture ManagementCorporate Venture CapitalMinority000 0000000 0000
    InterWest PartnersVenture CapitalMinority000 0000000 0000
    Sutter Hill VenturesVenture CapitalMinority000 0000000 0000
    Astellas Venture Management Corporate Venture Capital
    InterWest Partners Venture Capital
    Sutter Hill Ventures Venture Capital
    Request full access to PitchBook